Variant report

Variant	esv3497465
Chromosome Location	chr10:50322646-50324644
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:190)
CpG islands
(count:488)
Chromatin interactive
region (count:2)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:190 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr10:50323742-50323798	K562	blood:	n/a	n/a
2	ATF3	chr10:50323426-50323778	K562	blood:	n/a	chr10:50323542-50323562
3	BACH1	chr10:50322997-50323317	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr10:50323658-50323952	H1-hESC	embryonic stem cell:	n/a	n/a
5	BATF	chr10:50324193-50324568	GM12878	blood:	n/a	n/a
6	BHLHE40	chr10:50323737-50323937	K562	blood:	n/a	n/a
7	BHLHE40	chr10:50323013-50323326	K562	blood:	n/a	n/a
8	BRCA1	chr10:50323099-50323329	H1-hESC	embryonic stem cell:	n/a	n/a
9	CBX3	chr10:50323554-50323957	K562	blood:	n/a	n/a
10	CBX3	chr10:50323620-50323895	K562	blood:	n/a	n/a
11	CCNT2	chr10:50323077-50323857	K562	blood:	n/a	chr10:50323655-50323664
12	CHD1	chr10:50322975-50323188	H1-hESC	embryonic stem cell:	n/a	n/a
13	CHD2	chr10:50324251-50324451	GM12878	blood:	n/a	n/a
14	CHD2	chr10:50323045-50323384	H1-hESC	embryonic stem cell:	n/a	n/a
15	CHD2	chr10:50322965-50323427	K562	blood:	n/a	n/a
16	CHD2	chr10:50323123-50323273	HepG2	liver:	n/a	n/a
17	CTCF	chr10:50323180-50323330	HRE	kidney:	n/a	n/a
18	CTCF	chr10:50323540-50323547	GM13977	blood:	n/a	n/a
19	CTCF	chr10:50323490-50323611	GM19240	blood:	n/a	n/a
20	CTCF	chr10:50323501-50323602	GM10248	blood:	n/a	n/a
21	CTCF	chr10:50323339-50323359	GM12891	blood:	n/a	n/a
22	CTCF	chr10:50323060-50323210	AG04450	lung:	n/a	n/a
23	CTCF	chr10:50323315-50323320	Kidney_OC	kidney:	n/a	n/a
24	CTCF	chr10:50323000-50323150	HBMEC	blood vessel:	n/a	n/a
25	CTCF	chr10:50323341-50323376	Kidney_OC	kidney:	n/a	n/a
26	CTCF	chr10:50323020-50323170	HMF	breast:	n/a	n/a
27	CTCF	chr10:50323511-50323579	ProgFib	skin:	n/a	n/a
28	CTCF	chr10:50323462-50323588	HepG2	liver:	n/a	n/a
29	CTCF	chr10:50322900-50323050	AG10803	skin:	n/a	n/a
30	CTCF	chr10:50323290-50323379	GM13976	blood:	n/a	n/a
31	CTCF	chr10:50323020-50323170	BJ	skin:	n/a	n/a
32	CTCF	chr10:50323512-50323630	Pancreas_OC	pancreas:	n/a	n/a
33	CTCF	chr10:50323275-50323371	H1-hESC	embryonic stem cell:	n/a	n/a
34	CTCF	chr10:50323239-50323243	A549	lung:	n/a	n/a
35	CTCF	chr10:50323479-50323600	GM10266	blood:	n/a	n/a
36	CTCF	chr10:50323140-50323290	HAc	cerebellar:	n/a	n/a
37	CTCF	chr10:50323260-50323410	GM12868	blood:	n/a	n/a
38	CTCF	chr10:50323495-50323594	Gliobla	brain:	n/a	n/a
39	CTCF	chr10:50323160-50323310	GM12866	blood:	n/a	n/a
40	CTCF	chr10:50322980-50323130	AG04449	skin:	n/a	n/a
41	CTCF	chr10:50323260-50323550	GM12874	blood:	n/a	n/a
42	CTCF	chr10:50323200-50323350	GM12871	blood:	n/a	n/a
43	CTCF	chr10:50322840-50322990	HPF	lung:	n/a	n/a
44	CTCF	chr10:50323220-50323370	WERI-Rb-1	eye:	n/a	n/a
45	CTCF	chr10:50322980-50323130	AG10803	skin:	n/a	n/a
46	CTCF	chr10:50323286-50323306	GM10266	blood:	n/a	n/a
47	CTCF	chr10:50323470-50323596	SK-N-SH_RA	brain:	n/a	n/a
48	CTCF	chr10:50323240-50323390	HCM	heart:	n/a	n/a
49	CTCF	chr10:50323520-50323670	AG09319	gingival:	n/a	n/a
50	CTCF	chr10:50323220-50323370	SK-N-SH_RA	brain:	n/a	n/a

(count:488 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr10:50323244-50323294	BE2_C	brain:	n/a
2	chr10:50323369-50323419	HPAEpiC	pulmonary alveolar:	n/a
3	chr10:50323706-50323756	BE2_C	brain:	n/a
4	chr10:50323706-50323756	Hela-S3	cervix:	n/a
5	chr10:50323708-50323758	HNPCEpiC	eye:	n/a
6	chr10:50323127-50323177	HMEC	breast:	n/a
7	chr10:50323369-50323419	AG09309	skin:	n/a
8	chr10:50323244-50323294	GM12891	blood:	n/a
9	chr10:50323829-50323879	GM12878	blood:	n/a
10	chr10:50323244-50323294	HL-60	blood:	n/a
11	chr10:50323832-50323882	GM06990	blood:	n/a
12	chr10:50323832-50323882	Caco-2	colon:	n/a
13	chr10:50323708-50323758	K562	blood:	n/a
14	chr10:50323708-50323758	AG09319	gingival:	n/a
15	chr10:50323369-50323419	GM12878	blood:	n/a
16	chr10:50323127-50323177	A549	lung:	n/a
17	chr10:50323832-50323882	AG10803	skin:	n/a
18	chr10:50323708-50323758	NT2-D1	testis:	n/a
19	chr10:50323369-50323419	HCM	heart:	n/a
20	chr10:50323127-50323177	HepG2	liver:	n/a
21	chr10:50323825-50323875	AG04450	lung:	fetal
22	chr10:50323832-50323882	HCT-116	colon:	n/a
23	chr10:50323706-50323756	NHBE	bronchial:	n/a
24	chr10:50323832-50323882	HCM	heart:	n/a
25	chr10:50323127-50323177	HRE	kidney:	n/a
26	chr10:50323244-50323294	PANC-1	pancreas:	n/a
27	chr10:50323832-50323882	HL-60	blood:	n/a
28	chr10:50323244-50323294	HCF	heart:	n/a
29	chr10:50323708-50323758	LNCaP	prostate:	n/a
30	chr10:50323127-50323177	LNCaP	prostate:	n/a
31	chr10:50323825-50323875	HMEC	breast:	n/a
32	chr10:50323832-50323882	ProgFib	skin:	n/a
33	chr10:50323127-50323177	HEEpiC	esophagus:	n/a
34	chr10:50323829-50323879	ProgFib	skin:	n/a
35	chr10:50323832-50323882	AG04449	skin:	fetal
36	chr10:50323706-50323756	HEEpiC	esophagus:	n/a
37	chr10:50323369-50323419	RPTEC	kidney:	n/a
38	chr10:50323127-50323177	SK-N-MC	brain:	n/a
39	chr10:50323825-50323875	SKMC	muscle:	n/a
40	chr10:50323829-50323879	HepG2	liver:	n/a
41	chr10:50323244-50323294	AG04450	lung:	fetal
42	chr10:50323832-50323882	GM19239	blood:	n/a
43	chr10:50323369-50323419	NHBE	bronchial:	n/a
44	chr10:50323829-50323879	AG04450	lung:	fetal
45	chr10:50323369-50323419	Caco-2	colon:	n/a
46	chr10:50323832-50323882	HepG2	liver:	n/a
47	chr10:50323369-50323419	MCF10A-Er-Src	breast:	n/a
48	chr10:50323832-50323882	K562	blood:	n/a
49	chr10:50323829-50323879	PANC-1	pancreas:	n/a
50	chr10:50323369-50323419	Hela-S3	cervix:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr10:50322283..50325786-chr10:50341748..50344745,3	K562	blood:
2	chr10:50322533..50324257-chr10:50507150..50509486,2	K562	blood:

No data

Variant related genes	Relation type
VSTM4	TF binding region
VSTM4	CpG island
ENSG00000177354	chromatin interactions
ENSG00000172538	chromatin interactions

Extended variants
information (count: 57 )
Associated
traits (count: 67 )

Variant overlapped rSNPs/rCNVs (count:57 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs72785062	chr10:50322683-50322684	Weak transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs56678944	chr10:50322684-50322685	Weak transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs35666409	chr10:50322702-50322703	Weak transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs546915512	chr10:50322740-50322741	Weak transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs538396941	chr10:50322752-50322753	Weak transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs12770876	chr10:50322757-50322758	Weak transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs57040525	chr10:50322775-50322776	Weak transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs538378476	chr10:50322779-50322780	Weak transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs575367334	chr10:50322807-50322808	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs34910416	chr10:50322838-50322839	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs544048513	chr10:50322847-50322848	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs115584120	chr10:50322933-50322934	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs372064305	chr10:50323009-50323010	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs574283368	chr10:50323028-50323029	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs369049807	chr10:50323052-50323053	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs559533623	chr10:50323073-50323074	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs548834691	chr10:50323102-50323103	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs533351432	chr10:50323133-50323134	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs551445566	chr10:50323163-50323164	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs563444910	chr10:50323164-50323165	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs114224190	chr10:50323212-50323213	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs548800600	chr10:50323215-50323216	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs567102368	chr10:50323295-50323296	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs141087200	chr10:50323348-50323349	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs546865154	chr10:50323374-50323375	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs568024249	chr10:50323402-50323403	Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs571413350	chr10:50323438-50323439	Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs538633530	chr10:50323704-50323705	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs143140276	chr10:50323709-50323710	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs368558610	chr10:50323752-50323753	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs114783688	chr10:50323799-50323800	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs142693718	chr10:50323832-50323833	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs537264473	chr10:50323836-50323837	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs115653734	chr10:50323857-50323858	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs556022629	chr10:50323900-50323901	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs536964816	chr10:50323901-50323902	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs541399562	chr10:50323916-50323917	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs368697585	chr10:50323973-50323974	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs191782612	chr10:50324109-50324110	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs181173019	chr10:50324135-50324136	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs545016824	chr10:50324138-50324139	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs563327754	chr10:50324169-50324170	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs550722588	chr10:50324177-50324178	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs185576168	chr10:50324179-50324180	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs560791140	chr10:50324213-50324214	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs528300401	chr10:50324218-50324219	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
47	rs190181681	chr10:50324226-50324227	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
48	rs571543520	chr10:50324270-50324271	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs35007047	chr10:50324271-50324272	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs12267388	chr10:50324331-50324332	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:67)

Disease	PMID	Source
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Esophageal cancer	21851588	CNVD
Prostate cancer	18632612	CNVD
Autism	18414403	CNVD
Cockayne syndrome	18421352	CNVD
Glioblastoma	16823260	CNVD
Medulloblastoma	16968546	CNVD
Neuroblastoma	17533364	CNVD
Cancer	21183584	CNVD
T-cell lymphomas	19863542	CNVD
Testicular germ cell tumor	18059402	CNVD
Squamous cell cancer	21044232	CNVD
Glioma	21971842	CNVD
Cancer	21637783	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Papillary thyroid carcinoma	21436994	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Obesity	21956041	CNVD
Renal cell carcinoma	18765545	CNVD
Developmental delay	21948486	CNVD
Dysmorphic features	21948486	CNVD
Epilepsy	21948486	CNVD
Breast cancer	21785460	CNVD
Intellectual disability	21948486	CNVD
Schizophrenia	23813976	CNVD
Intellectual disability	22045946	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Autism	21948486	CNVD
cleft palate	21948486	CNVD
Encephalopathy	21948486	CNVD
Lung cancer	18438408	CNVD
T-cell primary immunodeficiency	21948486	CNVD
Autism	22543975	CNVD
Breast cancer	21364760	CNVD
Developmental delay	21147756	CNVD
small cell lung cancer	20016488	CNVD
skeletal anomalies	21948486	CNVD
speech delay	21948486	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	21990379	CNVD
Myelofibrosis	22110671	CNVD
Metanephric adenoma	20802469	CNVD
Hypotonia	21948486	CNVD

Chromatin state (count:252 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:50312600-50322800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
2	chr10:50315400-50323000	Weak transcription	Pancreas	Pancrea
3	chr10:50315600-50323000	Weak transcription	Spleen	Spleen
4	chr10:50318200-50322800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr10:50319000-50322800	Weak transcription	Esophagus	oesophagus
6	chr10:50319800-50323000	Weak transcription	Lung	lung
7	chr10:50321000-50323200	Flanking Active TSS	Adipose Nuclei	Adipose
8	chr10:50321600-50322800	Flanking Active TSS	Stomach Smooth Muscle	stomach
9	chr10:50321600-50323000	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
10	chr10:50321800-50324000	Bivalent/Poised TSS	Rectal Mucosa Donor 29	rectum
11	chr10:50322000-50322800	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
12	chr10:50322000-50322800	Flanking Active TSS	Colon Smooth Muscle	Colon
13	chr10:50322000-50322800	Flanking Active TSS	NHDF-Ad	bronchial
14	chr10:50322000-50323000	Bivalent/Poised TSS	Fetal Intestine Small	intestine
15	chr10:50322000-50323000	Flanking Active TSS	Fetal Muscle Leg	muscle
16	chr10:50322000-50323200	Flanking Active TSS	Fetal Adrenal Gland	Adrenal Gland
17	chr10:50322000-50323200	Flanking Active TSS	NHLF	lung
18	chr10:50322000-50324000	Active TSS	Duodenum Smooth Muscle	Duodenum
19	chr10:50322200-50322800	Enhancers	Brain Anterior Caudate	brain
20	chr10:50322200-50322800	Weak transcription	Brain Substantia Nigra	brain
21	chr10:50322200-50322800	Active TSS	Fetal Muscle Trunk	muscle
22	chr10:50322200-50323000	Flanking Active TSS	Brain Hippocampus Middle	brain
23	chr10:50322200-50323800	Active TSS	Right Ventricle	heart
24	chr10:50322200-50324000	Active TSS	Aorta	Aorta
25	chr10:50322200-50324600	Active TSS	Brain Cingulate Gyrus	brain
26	chr10:50322400-50322800	Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
27	chr10:50322400-50322800	Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
28	chr10:50322400-50322800	Active TSS	Colonic Mucosa	Colon
29	chr10:50322400-50322800	Flanking Active TSS	Fetal Stomach	stomach
30	chr10:50322400-50323800	Active TSS	Left Ventricle	heart
31	chr10:50322400-50323800	Active TSS	Ovary	ovary
32	chr10:50322400-50323800	Active TSS	Skeletal Muscle Male	skeletal muscle
33	chr10:50322400-50324000	Bivalent/Poised TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
34	chr10:50322400-50324000	Active TSS	Right Atrium	heart
35	chr10:50322400-50324000	Active TSS	HSMMtube	muscle
36	chr10:50322600-50322800	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
37	chr10:50322600-50322800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
38	chr10:50322600-50322800	Enhancers	Cortex derived primary cultured neurospheres	brain
39	chr10:50322600-50322800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
40	chr10:50322600-50322800	Enhancers	Liver	Liver
41	chr10:50322600-50322800	Active TSS	Brain Angular Gyrus	brain
42	chr10:50322600-50322800	Flanking Active TSS	HSMM	muscle
43	chr10:50322600-50322800	Active TSS	Osteobl	bone
44	chr10:50322600-50323000	Flanking Active TSS	Brain Inferior Temporal Lobe	brain
45	chr10:50322600-50323000	Bivalent/Poised TSS	Fetal Brain Female	brain
46	chr10:50322600-50323200	Flanking Bivalent TSS/Enh	Fetal Thymus	thymus
47	chr10:50322600-50323200	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
48	chr10:50322600-50323200	Flanking Active TSS	K562	blood
49	chr10:50322600-50323400	Bivalent/Poised TSS	Primary T cells from cord blood	blood
50	chr10:50322600-50323400	Bivalent/Poised TSS	Rectal Mucosa Donor 31	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links